Pathobiology 2027

Mechanisms of Disease

May 1-4, 2027

Flamingo Las Vegas, Las Vegas, NW

Session 024 – Autophagy in Liver Disease: Pathobiology and Therapeutic Implications

2:00-3:45 PM
Sponsored by the Liver Pathobiology Scientific Interest Group
Session Room: TBD

Session Co-Chairs

Kari Nejak-Bowen

Kari Nejak-Bowen, PhD
University of Pittsburgh School of Medicine

Wen-Xing Ding

Wen-Xing Ding, PhD
Kansas University Medical Center

Session Overview

Autophagy is a catabolic process that results in clearance of abnormal or damaged proteins and organelles that would otherwise accumulate and lead to cellular stress. In the liver, autophagy also plays an important role in maintaining cellular and metabolic homeostasis by providing nutrients for energy production. Dysregulated autophagy can lead to liver diseases such as metabolic dysfunction-associated steatotic liver disease, drug-induced liver injury, cholestasis, and cancer. This session will explore the molecular mechanisms underlying autophagy, and also discuss how dysregulated hepatic autophagy exacerbates disease. Therapeutic implications of modulating autophagy in liver disease will also be discussed.

Agenda

  • Co-Chair – Welcome and Introductions

  • Wen-Xing Ding2:00-2:25 PM
    The End is the Beginning: Lessons Learned from TFEB in Alcohol-Associated Liver Disease and Cancer
    Wen-Xing Ding, PhD
    Kansas University Medical Center

  • Kari Nejak-Bowen2:25-2:50 PM
    Therapeutic Strategies to Enhance Autophagy in Porphyria
    Kari Nejak-Bowen, PhD
    University of Pittsburgh School of Medicine

  • Congcong He2:50-3:15 PM
    Exercise Activates Hepatic Autophagy to Mitigate MASH
    CongCong He, PhD
    Northwestern University

  • Ling Yang3:15-3:45 PM
    Lysosomes in Metabolic Liver Diseases
    Ling Yang, PhD
    University of Iowa Carver College of Medicine